Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial
Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a newer iteration. This is a minor update to the page's version and does not alter study content or how the page operates.SummaryDifference0.0%

- Check30 days agoChange DetectedSite revision updated to v3.5.2.SummaryDifference0.0%

- Check45 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the Locations section.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision: v3.4.2 was added, replacing v3.4.1, indicating a minor update. This does not modify study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.